# Perioperative Closed-loop Glucose Control

> **NCT04361799** · NA · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 45 (actual)

## Conditions studied

- Perioperative Hyperglycaemia
- Insulin Therapy
- Elective Surgery
- Closed-Loop Glucose Control
- Artificial Pancreas

## Interventions

- **DEVICE:** CamAPS
- **DRUG:** Standard insulin therapy

## Key facts

- **NCT ID:** NCT04361799
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-25
- **Primary completion:** 2021-09-02
- **Final completion:** 2021-09-02
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2021-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04361799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04361799, "Perioperative Closed-loop Glucose Control". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04361799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*